{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:39:06Z","timestamp":1787503146169,"version":"build-2736575974"},"update-to":[{"DOI":"10.1002\/14651858.cd012167","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T00:00:00Z","timestamp":1548115200000}}],"reference-count":179,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd012167.pub2","type":"journal-article","created":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T06:35:30Z","timestamp":1548138930000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Oral H1 antihistamines as \u2018add-on\u2019 therapy to topical treatment for eczema"],"prefix":"10.1002","volume":"2019","author":[{"given":"Uwe","family":"Matterne","sequence":"first","affiliation":[{"name":"University of Regensburg; Medical Sociology, Institute of Epidemiology and Preventive Medicine; Regensburg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merle Margarete","family":"B\u00f6hmer","sequence":"additional","affiliation":[{"name":"University of Regensburg; Medical Sociology, Institute of Epidemiology and Preventive Medicine; Regensburg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"Weisshaar","sequence":"additional","affiliation":[{"name":"Heidelberg University Hospital; Department of Clinical Social Medicine; Thibautstrasse 3 Heidelberg Germany 69115"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldrin","family":"Jupiter","sequence":"additional","affiliation":[{"name":"Heidelberg University Hospital; Department of Clinical Social Medicine; Thibautstrasse 3 Heidelberg Germany 69115"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Carter","sequence":"additional","affiliation":[{"name":"King's College London; Institute of Psychiatry, Psychology & Neuroscience; Biostatistics and Health Informatics; Denmark Hill London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian J","family":"Apfelbacher","sequence":"additional","affiliation":[{"name":"University of Regensburg; Medical Sociology, Institute of Epidemiology and Preventive Medicine; Regensburg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,1,22]]},"reference":[{"issue":"5","key":"10.1002\/14651858.CD012167.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1365-2133.1989.tb08196.x","article-title":"Failure of terfenadine in relieving the pruritus of atopic dermatitis","volume":"121","author":"Berth-Jones","year":"1989","journal-title":"British Journal of Dermatology"},{"key":"10.1002\/14651858.CD012167.pub2-BIB0002|cit2","unstructured":"Cambazard F UCB Pharma Efficacy and safety of cetirizine drops at 3 doses (0.25, 0.50, 0.75 mg\/kg bw\/day) in an 8-week treatment of atopic dermatitis in 1 to 5 year old children: a multicentric, multi-country, double-blind, placebo-controlled, randomised study, 2001 art45-paediatric-studies-docs.ema.europa.eu\/GROUP%20C\/UCB_Cetirizine\/Clinical%20Study%20Reports%20-%20Cetirizine%20(part%203)\/9708%20-%20Cetirizine%20-%20MRCE00H0202.pdf"},{"issue":"S16","key":"10.1002\/14651858.CD012167.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ppul.1950230842","article-title":"Early treatment of the atopic child: first results of the clinical trial","volume":"23","author":"Businco","year":"1997","journal-title":"Pediatric Pulmonology. Supplement"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD012167.pub2-BIB0004|cit4","first-page":"S133","article-title":"Impact of cetirizine on atopic dermatitis","volume":"12","author":"Diepgen","year":"1999","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"4","key":"10.1002\/14651858.CD012167.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1034\/j.1399-3038.2002.01047.x","article-title":"Long-term treatment with cetirizine of infants with atopic dermatitis: a multi-country, double-blind, randomized, placebo-controlled trial (the ETAC trial) over 18 months","volume":"13","author":"Diepgen","year":"2002","journal-title":"Pediatric Allergy and Immunology"},{"issue":"5","key":"10.1002\/14651858.CD012167.pub2-BIB0006|cit6","first-page":"244","article-title":"Prospective, long-term safety evaluation of the H1-receptor antagonist cetirizine in very young children with atopic dermatitis","volume":"23","author":"Estelle","year":"2000","journal-title":"Allergologie"},{"issue":"2 Pt 1","key":"10.1002\/14651858.CD012167.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0091-6749(99)70389-1","article-title":"Prospective, long-term safety evaluation of the H1-receptor antagonist cetirizine in very young children with atopic dermatitis","volume":"104","author":"Simons","year":"1999","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"2","key":"10.1002\/14651858.CD012167.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1203\/00006450-200208000-00018","article-title":"Long-term evaluation of the impact of the H1-receptor antagonist cetirizine on the behavioral, cognitive, and psychomotor development of very young children with atopic dermatitis","volume":"52","author":"Stevenson","year":"2002","journal-title":"Pediatric Research"},{"issue":"6666","key":"10.1002\/14651858.CD012167.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1136\/bmj.298.6666.96","article-title":"Treatment of itching in atopic eczema with antihistamines with a low sedative profile","volume":"298","author":"Doherty","year":"1989","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD012167.pub2-BIB0010|cit10","first-page":"63","article-title":"Ketotifen in the treatment of atopic dermatitis. Results of a double blind study","volume":"15","author":"Falk","year":"1993","journal-title":"European Review for Medical and Pharmacological Sciences"},{"issue":"1","key":"10.1002\/14651858.CD012167.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/BF00412560","article-title":"A double blind trial of H1 and H2 receptor antagonists in the treatment of atopic dermatitis","volume":"276","author":"Frosch","year":"1984","journal-title":"Archives of Dermatological Research"},{"issue":"1-2","key":"10.1002\/14651858.CD012167.pub2-BIB0012|cit12","first-page":"164","article-title":"Results of a double blind study with H1- and H2-histaminereceptor antagonists in atopic dermatitis","volume":"273","author":"Schwanitz","year":"1992","journal-title":"Archives of Dermatological Research"},{"issue":"2","key":"10.1002\/14651858.CD012167.pub2-BIB0013|cit13","first-page":"127","article-title":"Dose ranging study: cetirizine in the treatment of atopic dermatitis in adults","volume":"70","author":"Hannuksela","year":"1993","journal-title":"Annals of Allergy"},{"issue":"2","key":"10.1002\/14651858.CD012167.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1398-9995.1998.tb03867.x","article-title":"Differential effects of new-generation H1-receptor antagonists in pruritic dermatoses","volume":"53","author":"Henz","year":"1998","journal-title":"Allergy"},{"issue":"4A","key":"10.1002\/14651858.CD012167.pub2-BIB0015|cit15","first-page":"29","article-title":"Terfenadine in the treatment of chronic idiopathic urticaria and atopic dermatitis","volume":"42","author":"Hjorth","year":"1988","journal-title":"Cutis; Cutaneous Medicine for the Practitioner"},{"issue":"2","key":"10.1002\/14651858.CD012167.pub2-BIB0016|cit16","first-page":"132","article-title":"A double blind study of the effectiveness of ketotifen in preventing the development of asthma in atopic dermatitis patients","volume":"40","author":"Iikura","year":"1991","journal-title":"Arerugi [Allergy]"},{"issue":"3","key":"10.1002\/14651858.CD012167.pub2-BIB0017|cit17","first-page":"233","article-title":"Prevention of asthma by ketotifen in infants with atopic dermatitis","volume":"68","author":"Iikura","year":"1992","journal-title":"Annals of Allergy"},{"key":"10.1002\/14651858.CD012167.pub2-BIB0018|cit18","unstructured":"Jung EG Kaymer FG Ring J Casimir G de Bersaques J de la Brassine M Multicentre double-blind study in parallel groups, comparing to placebo 5 and 10 mg cetirizine administered in two daily doses for a week, to children aged 3 - 6 years suffering from atopic dermatitis - determination of the antipruritic effect. UCB Pharmaceutical Sector, 1989 http:\/\/art45-paediatric-studies-docs.ema.europa.eu\/GROUP%20C\/UCB_Cetirizine\/Clinical%20Study%20Reports%20-%20Cetirizine%20(part%203)\/A103%20-%20Cetirizine%20-%20CE89G241.pdf (accessed 26 April 2017)"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012167.pub2-BIB0020|cit19","first-page":"S160","article-title":"Fexofenadine is effective at reducing itching associated with atopic dermatitis","volume":"109","author":"Kawashima","year":"2002","journal-title":"Journal of Allergy, Asthma and Immunolgy"},{"issue":"Suppl 1 Pt 2","key":"10.1002\/14651858.CD012167.pub2-BIB0019|cit20","first-page":"1S413","article-title":"Fexofenadine is effective at reducing itching associated with atopic dermatitis","volume":"129","author":"Kawashima","year":"2002","journal-title":"Annales de Dermatologie et de Venereologie"},{"issue":"6","key":"10.1002\/14651858.CD012167.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1046\/j.1365-2133.2003.05293.x","article-title":"Addition of fexofenadine to a topical corticosteroid reduces the pruritus associated with atopic dermatitis in a 1-week randomized, multicentre, double-blind, placebo-controlled, parallel-group study","volume":"148","author":"Kawashima","year":"2003","journal-title":"British Journal of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD012167.pub2-BIB0022|cit22","first-page":"125","article-title":"Usefulness of TARC in serum as treatment marker and combination treatment with loratadine and steroid ointment for atopic dermatitis","volume":"8","author":"Kimura","year":"2009","journal-title":"Skin Research"},{"key":"10.1002\/14651858.CD012167.pub2-BIB0023|cit23","unstructured":"Kircik L Management of pruritus with Xyzal in atopic dermatitis, 2013 https:\/\/clinicaltrials.gov\/ct2\/show\/results\/NCT00884325?term=levocetirizine&recrs=e&rslt=With&type=Intr&cond=Atopic+Dermatitis&rank=1&sect=X70156"},{"issue":"2","key":"10.1002\/14651858.CD012167.pub2-BIB0024|cit24","first-page":"166","article-title":"Management of pruritus with levocetirizine dihydrochloride in atopic dermatitis in a randomized, double-blind, placebo controlled study - Interim analysis of 21 subjects","volume":"31","author":"Kircik","year":"2010","journal-title":"Allergy and Asthma Proceedings"},{"issue":"5","key":"10.1002\/14651858.CD012167.pub2-BIB0025|cit25","doi-asserted-by":"publisher","first-page":"526","DOI":"10.2336\/nishinihonhifu.71.526","article-title":"Examination of olopatadine hydrochloride for anti-itching and topical-steroid sparing effects in patients with chronic eczema or dermatitis","volume":"71","author":"Kuniyuki","year":"2009","journal-title":"Nishinihon Journal of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD012167.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1398-9995.1994.tb00768.x","article-title":"Therapeutic effect of loratadine on pruritus in patients with atopic dermatitis. A multi-crossover-designed study","volume":"49","author":"Langeland","year":"1994","journal-title":"Allergy"},{"issue":"2","key":"10.1002\/14651858.CD012167.pub2-BIB0027|cit27","first-page":"117","article-title":"Double-blind study of cetirizine in atopic eczema in children","volume":"73","author":"Rosa","year":"1994","journal-title":"Annals of Allergy"},{"issue":"3","key":"10.1002\/14651858.CD012167.pub2-BIB0028|cit28","first-page":"153","article-title":"Tolerance and efficacy of ketotifen in children with atopic dermatitis","volume":"33","author":"Leon","year":"1989","journal-title":"Dermatologia Revista Mexicana"},{"issue":"1","key":"10.1002\/14651858.CD012167.pub2-BIB0029|cit29","first-page":"17","article-title":"Relative efficacy and safety of loratadine, hydroxyzine, and placebo in chronic idiopathic urticaria and atopic dermatitis","volume":"14","author":"Monroe","year":"1992","journal-title":"Clinical Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD012167.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000063138","article-title":"Chlorpheniramine is no more effective than placebo in relieving the symptoms of childhood atopic dermatitis with a nocturnal itching and scratching component","volume":"205","author":"Munday","year":"2002","journal-title":"Dermatology (Basel, Switzerland)"},{"issue":"2","key":"10.1002\/14651858.CD012167.pub2-BIB0031|cit31","first-page":"137","article-title":"Treatment of atopic dermatitis with antihistamines: lessons from a single-patient, randomized clinical trial","volume":"5","author":"Nuovo","year":"1992","journal-title":"Journal of the American Board of Family Practice"},{"issue":"4","key":"10.1002\/14651858.CD012167.pub2-BIB0032|cit32","first-page":"1","article-title":"Atopisches ekzem: behandlung mit loratadin","volume":"46","author":"Ruzicka","year":"1998","journal-title":"Der Deutsche Dermatologe"},{"issue":"6","key":"10.1002\/14651858.CD012167.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1365-2230.1986.tb00515.x","article-title":"The effect of a new non-sedative Hsub 1-receptor antagonist (LN2974) on the itching and scratching of patients with atopic eczema","volume":"11","author":"Savin","year":"1986","journal-title":"Clinical and Experimental Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD012167.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1399-3038.2007.00558.x","article-title":"Safety of levocetirizine treatment in young atopic children: an 18-month study","volume":"18","author":"Simons","year":"2007","journal-title":"Pediatric Allergy and Immunology"},{"issue":"3","key":"10.1002\/14651858.CD012167.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S1081-1206(10)60662-X","article-title":"H1-antihistamine treatment in young atopic children: effect on urticaria","volume":"99","author":"Simons","year":"2007","journal-title":"Annals of Allergy, Asthma & Immunology"},{"key":"10.1002\/14651858.CD012167.pub2-BIB0036|cit36","first-page":"110","article-title":"A double blind parallel study of cetirizine C 20 mg and placebo P in the management of patients with atopic dermatitis AD","volume":"80","author":"Tharp","year":"1998","journal-title":"Annals of Allergy, Asthma and Immunology"},{"key":"10.1002\/14651858.CD012167.pub2-BIB0037|cit37","first-page":"68","article-title":"Bikarfen - a new Soviet antihistaminic and antiserotonin preparation in the therapy of allergic dermatoses","volume":"10","author":"Anton'ev","year":"1988","journal-title":"Vestnik Dermatologii i Venerologii"},{"key":"10.1002\/14651858.CD012167.pub2-BIB0038|cit38","first-page":"37","article-title":"Effectiveness of the use of zaditen in allergic dermatoses and the dermorespiratory syndrome in children","volume":"7","author":"Balabolkin","year":"1983","journal-title":"Pediatriia"},{"issue":"3","key":"10.1002\/14651858.CD012167.pub2-BIB0039|cit39","first-page":"349","article-title":"Trial of clinical evaluation of Doxergan, a new antihistaminic drug","volume":"55","author":"Bogdaszewska-Czabanowska","year":"1968","journal-title":"Przeglad Dermatologiczny"},{"issue":"8","key":"10.1002\/14651858.CD012167.pub2-BIB0040|cit40","first-page":"410","article-title":"Terfenadine compared to clemastine in the treatment of pruriginous cutaneous diseases. Double-blind comparative study","volume":"181","author":"Castro Torres","year":"1987","journal-title":"Revista Cl\u00ednica Espa\u00f1ola"},{"issue":"38","key":"10.1002\/14651858.CD012167.pub2-BIB0041|cit41","first-page":"630","article-title":"Experience with a new antihistaminic in dermatology. Results of a clinical double blind trial [German]","volume":"119","author":"Eberhartinger","year":"1969","journal-title":"Wiener Klinische Wochenschrift"},{"issue":"4","key":"10.1002\/14651858.CD012167.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1365-2222.1981.tb01600.x","article-title":"A double-blind trial of the H2 receptor antagonist cimetidine, and the H1 receptor antagonist promethazine hydrochloride in the treatment of atopic dermatitis","volume":"11","author":"Foulds","year":"1981","journal-title":"Clinical Allergy"},{"issue":"3","key":"10.1002\/14651858.CD012167.pub2-BIB0043|cit43","doi-asserted-by":"publisher","first-page":"321","DOI":"10.2336\/nishinihonhifu.71.321","article-title":"Efficacy of ebastine for treatment of pruritic skin disease: patient assessment with a self-administered questionnaire","volume":"71","author":"Furue","year":"2009","journal-title":"Nishinihon Journal of Dermatology"},{"issue":"36","key":"10.1002\/14651858.CD012167.pub2-BIB0044|cit44","first-page":"625","article-title":"Clinical and experimental studies with the antihistaminic Tavegyl in dermatologic patients","volume":"82","author":"Grabner","year":"1970","journal-title":"Wiener Klinische Wochenschrift"},{"issue":"1","key":"10.1002\/14651858.CD012167.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0923-1811(03)00132-4","article-title":"Effective treatment of pruritus in atopic dermatitis using H1 antihistamines (second-generation antihistamines): changes in blood histamine and tryptase levels","volume":"33","author":"Imaizumi","year":"2003","journal-title":"Journal of Dermatological Science"},{"issue":"2","key":"10.1002\/14651858.CD012167.pub2-BIB0046|cit46","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jdermsci.2006.04.002","article-title":"Oral antihistamine therapy influences plasma tryptase levels in adult atopic dermatitis","volume":"43","author":"Kawakami","year":"2006","journal-title":"Journal of Dermatological Science"},{"issue":"2","key":"10.1002\/14651858.CD012167.pub2-BIB0047|cit47","first-page":"108","article-title":"Testing and use of 9,9-dioxopromethazine (Prothanon) as an antihistaminic and antipruritic agent in dermatology","volume":"25","author":"Kleine-Natrop","year":"1970","journal-title":"Die Pharmazie"},{"issue":"4","key":"10.1002\/14651858.CD012167.pub2-BIB0048|cit48","first-page":"204","article-title":"Dimethindene maleate (DMM) in a therapeutic comparison with 2nd generation antihistamines","volume":"6","author":"Kori-Lindner","year":"1997","journal-title":"Allergo Journal"},{"issue":"3","key":"10.1002\/14651858.CD012167.pub2-BIB0049|cit49","first-page":"95","article-title":"Evaluation of peritol in the management of allergic diseases of the skin","volume":"20","author":"Korossy","year":"1972","journal-title":"Therapia Hungarica (English Edition)"},{"issue":"3","key":"10.1002\/14651858.CD012167.pub2-BIB0050|cit50","first-page":"161","article-title":"Effect observation of eczema treated with combined traditional Chinese medicine for external use with cetirizine and hydrocortisone butyrate","volume":"15","author":"Liu","year":"2008","journal-title":"Southern China Journal of Dermato-venereology [ Lingnan Pi Fu Xing Bing Ke za Zhi ]"},{"issue":"11","key":"10.1002\/14651858.CD012167.pub2-BIB0051|cit51","first-page":"1196","article-title":"Comparative study of the efficacy and safety of loratadine syrup and terfenadine suspension in the treatment of chronic allergic skin diseases in a pediatric population","volume":"43","author":"Lutsky","year":"1993","journal-title":"Arzneimittel-Forschung"},{"issue":"4","key":"10.1002\/14651858.CD012167.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1398-9995.1966.tb03133.x","article-title":"The antipruritic effect of Fenistil (dimethypyrindene) in allergic conditions. Double blind clinical study","volume":"21","author":"May","year":"1966","journal-title":"Acta Allergologica"},{"issue":"8","key":"10.1002\/14651858.CD012167.pub2-BIB0053|cit53","first-page":"498","article-title":"Antihistamine therapy in allergic skin disease. Comparison between loratadine and dimetindene","volume":"67","author":"Mensing","year":"1991","journal-title":"Zeitschrift fur Allgemeinmedizin"},{"issue":"3","key":"10.1002\/14651858.CD012167.pub2-BIB0054|cit54","first-page":"202","article-title":"Dimetindene versus astemizole in the treatment of itching eczematous disorders: a randomized, double-blind, comparative trial","volume":"4","author":"Mesquita","year":"1994","journal-title":"European Journal of Dermatology"},{"key":"10.1002\/14651858.CD012167.pub2-BIB0055|cit55","first-page":"692","article-title":"Clinical trial of a multiphasic antihistaminic preparation (clemizole, quercetin, amphetamine)","volume":"21","author":"Miller","year":"1963","journal-title":"Annals of Allergy"},{"issue":"2","key":"10.1002\/14651858.CD012167.pub2-BIB0056|cit56","first-page":"111","article-title":"The introduction of 9,9-dioxopromethazine (Prothanon) into the treatment of skin diseases in hospitalized patients","volume":"25","author":"Nitzschner","year":"1970","journal-title":"Die Pharmazie"},{"issue":"4","key":"10.1002\/14651858.CD012167.pub2-BIB0057|cit57","doi-asserted-by":"publisher","first-page":"533","DOI":"10.2332\/allergolint.13-RA-0675","article-title":"The role of histamine H1 and H4 receptors in atopic dermatitis: from basic research to clinical study","volume":"63","author":"Ohsawa","year":"2014","journal-title":"Allergology International"},{"issue":"3","key":"10.1002\/14651858.CD012167.pub2-BIB0058|cit58","first-page":"316","article-title":"Usefulness of anti-histamine drugs in treatment of facial atopic dermatitis: their effect on the dose-reduction maintenance of tacrolimus ointments used for facial lesions","volume":"3","author":"Ohtani","year":"2004","journal-title":"Skin Research"},{"issue":"3","key":"10.1002\/14651858.CD012167.pub2-BIB0059|cit59","first-page":"119","article-title":"Controlled study of oxatomide vs disodium chromoglycate for treating adverse reactions to food","volume":"18","author":"Pacor","year":"1992","journal-title":"Drugs Under Experimental and Clinical Research"},{"issue":"4","key":"10.1002\/14651858.CD012167.pub2-BIB0060|cit60","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3109\/09546639709160530","article-title":"A double-blind study of loratadine and cetirizine in atopic dermatitis","volume":"8","author":"Patel","year":"1997","journal-title":"Journal of Dermatological Treatment"},{"issue":"3","key":"10.1002\/14651858.CD012167.pub2-BIB0061|cit61","first-page":"228","article-title":"Acupuncture compared with oral antihistamine for type I hypersensitivity itch and skin response in adults with atopic dermatitis - a patient- and examiner-blinded, randomized, placebo-controlled, crossover trial","volume":"20","author":"Pfab","year":"2012","journal-title":"Revista Portuguesa de Imunoalergologia"},{"issue":"4","key":"10.1002\/14651858.CD012167.pub2-BIB0062|cit62","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/j.1398-9995.2012.02789.x","article-title":"Acupuncture compared with oral antihistamine for type I hypersensitivity itch and skin response in adults with atopic dermatitis: a patient- and examiner-blinded, randomized, placebo-controlled, crossover trial","volume":"67","author":"Pfab","year":"2012","journal-title":"Allergy: European Journal of Allergy and Clinical Immunology"},{"key":"10.1002\/14651858.CD012167.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000254521","article-title":"Therapeutic trial with antipruritic drugs","volume":"130","author":"Rajka","year":"1965","journal-title":"Dermatologica"},{"issue":"2","key":"10.1002\/14651858.CD012167.pub2-BIB0064|cit64","first-page":"93","article-title":"Evaluation of drug influence on the itch duration in the skin of patients with atopic dermatitis, various eczemas and psoriasis. I. Experiments in involved skin. Comparison with itch threshold technique","volume":"48","author":"Rajka","year":"1968","journal-title":"Acta Dermato-Venereologica"},{"issue":"2","key":"10.1002\/14651858.CD012167.pub2-BIB0065|cit65","first-page":"98","article-title":"Evaluation of drug influence on the itch duration in the skin of patients with atopic dermatitis, various eczemas and psoriasis. II. Experiments in unaffected skin. Comparison with itch threshold technique and clinical evaluation","volume":"48","author":"Rajka","year":"1968","journal-title":"Acta Dermato-Venereologica"},{"key":"10.1002\/14651858.CD012167.pub2-BIB0066|cit66","first-page":"1442","article-title":"Antihistamine therapy of itching skin disorders-results of a multi-centre outpatient study","volume":"40","author":"Schmoeckel","year":"1992","journal-title":"Dt Dermatologe"},{"issue":"7","key":"10.1002\/14651858.CD012167.pub2-BIB0067|cit67","first-page":"440","article-title":"The clinical and immunological study of the mizolastine on the eczema and atopic dermatitis","volume":"38","author":"Sheng","year":"2009","journal-title":"Journal of Clinical Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD012167.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0022-3476(84)80608-3","article-title":"Pharmacokinetics and antipruritic effects of hydroxyzine in children with atopic dermatitis","volume":"104","author":"Simons","year":"1984","journal-title":"Journal of Pediatrics"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD012167.pub2-BIB0069|cit69","first-page":"174","article-title":"Combination therapy with 0.1% tacrolimus ointment and cetirizine for facial atopic dermatitis","volume":"17","author":"Sugai","year":"2003","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"51-52","key":"10.1002\/14651858.CD012167.pub2-BIB0070|cit70","first-page":"1672","article-title":"A new generation of antihistaminics (H1)","volume":"43","author":"Tarchalska","year":"1988","journal-title":"Polski Tygodnik Lekarski"},{"issue":"6","key":"10.1002\/14651858.CD012167.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/0190-9622(95)91363-7","article-title":"Ranitidine treatment of hand eczema in patients with atopic dermatitis: a double-blind, placebo-controlled trial","volume":"32","author":"Veien","year":"1995","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"8","key":"10.1002\/14651858.CD012167.pub2-BIB0072|cit72","first-page":"254","article-title":"The antihistamine loratadine in the treatment of urticaria and itching eczema","volume":"15","author":"Voigtlander","year":"1989","journal-title":"Aktuelle Dermatologie"},{"issue":"4","key":"10.1002\/14651858.CD012167.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-2133.1990.tb14732.x","article-title":"The antipruritic effect of a sedative and a non-sedative antihistamine in atopic dermatitis","volume":"122","author":"Wahlgren","year":"1990","journal-title":"British Journal of Dermatology"},{"issue":"Suppl","key":"10.1002\/14651858.CD012167.pub2-BIB0074|cit74","first-page":"1","article-title":"Itch and atopic dermatitis: clinical and experimental studies","volume":"165","author":"Wahlgren","year":"1991","journal-title":"Acta Dermato-venereologica. Supplementum"},{"issue":"20","key":"10.1002\/14651858.CD012167.pub2-BIB0075|cit75","first-page":"1134","article-title":"Ambulatory testing of a new antihistaminic. Experience with Tavegil","volume":"109","author":"Weitgasser","year":"1967","journal-title":"Munchener Medizinische Wochenschrift (1950)"},{"issue":"38","key":"10.1002\/14651858.CD012167.pub2-BIB0076|cit76","first-page":"868","article-title":"Clinical experience with a new antihistaminic","volume":"117","author":"Wolfram","year":"1967","journal-title":"Wiener Medizinische Wochenschrift (1946)"},{"issue":"2","key":"10.1002\/14651858.CD012167.pub2-BIB0077|cit77","first-page":"85","article-title":"36 cases of terfenadine combining with IFN-gamma for atopic dermatitis","volume":"12","author":"Zhang","year":"1998","journal-title":"Chinese Journal of Dermatovenereology"},{"issue":"5","key":"10.1002\/14651858.CD012167.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0254-6272(10)60005-2","article-title":"Observation of clinical efficacy of Chinese medicine for 30 cases with infantile eczema","volume":"6","author":"Zhang","year":"2010","journal-title":"Journal of Pediatics of Traditional Chinese Medicine"},{"issue":"1","key":"10.1002\/14651858.CD012167.pub2-BIB0079|cit79","first-page":"7","article-title":"Comparative study of the effect of the hidroxicina the terfenadina and the astemizol in children with atopic dermatitis: Hospital General de Medellin-Centro de Especialistas cE.S. 1986-1988","volume":"3","author":"Zuluaga de Cadena","year":"1989","journal-title":"Revista CES Medicina"},{"issue":"3","key":"10.1002\/14651858.CD012167.pub2-BIB0080|cit80","first-page":"93","article-title":"Drug-induced changes in allergic mediatory reactivity in constitutional neurodermatitis patients","volume":"44","author":"Borelli","year":"1969","journal-title":"Zeitschrift f\u00fcr Haut- und Geschlechtskrankheiten"},{"issue":"4","key":"10.1002\/14651858.CD012167.pub2-BIB0081|cit81","first-page":"482","article-title":"Therapeutic efficacy and safety of loratadine syrup in childhood atopic dermatitis treated with mometasone furoate 0.1 per cent cream","volume":"85","author":"Chunharas","year":"2002","journal-title":"Journal of the Medical Association of Thailand"},{"issue":"12","key":"10.1002\/14651858.CD012167.pub2-BIB0082|cit82","first-page":"2463","article-title":"A double blind experimental study with a new synthetic antihistamine: mequitazine","volume":"3","author":"Beule","year":"1974","journal-title":"Ars Medici Internationaal Tijdschrift voor Praktische Therapie"},{"issue":"11","key":"10.1002\/14651858.CD012167.pub2-BIB0083|cit83","first-page":"1965","article-title":"Double blind test with a new antihistamine: Primalan (Mequitazine)","volume":"3","author":"Beule","year":"1974","journal-title":"Ars Medici Internationaal Tijdschrift voor Praktische Therapie"},{"issue":"5","key":"10.1002\/14651858.CD012167.pub2-BIB0084|cit84","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1185\/03007997809111900","article-title":"Comparative trial of antihistamine, mequitazine, and placebo","volume":"5","author":"Laugier","year":"1978","journal-title":"Current Medical Research and Opinion"},{"key":"10.1002\/14651858.CD012167.pub2-BIB0085|cit85","unstructured":"NCT00160563 Prevention of asthma with levocetirizine (36 month treatment) in young children suffering from eczema (atopic dermatitis) and sensitized to grass pollen and house dust mite and having completed the previous EPAAC trial (NCT00152464) clinicaltrials.gov\/ct2\/show\/NCT00160563"},{"issue":"6","key":"10.1002\/14651858.CD012167.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1067\/mai.2003.1496","article-title":"Safety of cetirizine in infants 6 to 11 months of age: a randomized, double-blind, placebo-controlled study","volume":"111","author":"Simons","year":"2003","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"10.1002\/14651858.CD012167.pub2-BIB0087|cit87","unstructured":"CRT EU 23679 Prednicarbat and cetirizin dihydrochloride in the treatment of acute stage of atopic eczema in children www.clinicaltrialsregister.eu\/ctr-search\/viewArt45\/23679"},{"key":"10.1002\/14651858.CD012167.pub2-BIB0088|cit88","unstructured":"CTR EU 23697 Effect of long-term treatment with the h 1 -receptor antagonist cetirizine in the prevention of urticaria in children with atopic dermatitis www.clinicaltrialsregister.eu\/ctr-search\/viewArt45\/23697"},{"key":"10.1002\/14651858.CD012167.pub2-BIB0089|cit89","unstructured":"CTR EU 29342 Hydroxyzine: pharmacokinetics and antipruritic effect in children with atopic dermatitis www.clinicaltrialsregister.eu\/ctr-search\/viewArt45\/29342"},{"key":"10.1002\/14651858.CD012167.pub2-BIB0090|cit90","unstructured":"CTR EU 39698 Evaluation of the efficacy and the safety of DCL syrup in childhood atopic dermatitis www.clinicaltrialsregister.eu\/ctr-search\/viewArt45\/39698"},{"key":"10.1002\/14651858.CD012167.pub2-BIB0091|cit91","unstructured":"UMIN000010519 JPRN-UMIN000010519 Impact of olopatadine hydrochloride (Allelock(R)) against scratching behavior of atopic dermatitis patients at night (Kuniyuki_2009 study as principal investigator Yamanaka but this registrations is from 2013 with anticipated start of trial 2013) upload.umin.ac.jp\/cgi-open-bin\/ctr_e\/ctr_view.cgi?recptno=R000012289"},{"key":"10.1002\/14651858.CD012167.pub2-BIB0092|cit92","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.neuroscience.2013.07.035","article-title":"Neural processing of itch","volume":"250","author":"Akiyama","year":"2013","journal-title":"Neuroscience"},{"issue":"2","key":"10.1002\/14651858.CD012167.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1398-9995.2010.02464.x","article-title":"Determinants of eczema: population-based cross-sectional study in Germany","volume":"66","author":"Apfelbacher","year":"2011","journal-title":"Allergy"},{"issue":"2","key":"10.1002\/14651858.CD012167.pub2-BIB0094|cit94","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007770.pub2","article-title":"Oral H1 antihistamines as monotherapy for eczema","author":"Apfelbacher","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012167.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1017\/CBO9780511545771.004","article-title":"The pathophysiology and clinical features of atopic dermatitis","volume-title":"Atopic Dermatitis","author":"Archer","year":"2000"},{"issue":"6","key":"10.1002\/14651858.CD012167.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.jaci.2007.08.067","article-title":"Toward a major risk factor for atopic eczema: meta-analysis of filaggrin polymorphism data","volume":"120","author":"Baurecht","year":"2007","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"10.1002\/14651858.CD012167.pub2-BIB0097|cit97","doi-asserted-by":"crossref","unstructured":"Bero LA Why the Cochrane risk of bias tool should include funding source as a standard item [editorial] Cochrane Database of Systematic Reviews 2013 10.1002\/14651858.ED000075","DOI":"10.1002\/14651858.ED000075"},{"issue":"14","key":"10.1002\/14651858.CD012167.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1056\/NEJMra074081","article-title":"Atopic dermatitis","volume":"358","author":"Bieber","year":"2008","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD012167.pub2-BIB0099|cit99","doi-asserted-by":"crossref","DOI":"10.1201\/9780367802875","volume-title":"Atopic Dermatitis","author":"Bieber","year":"2009"},{"key":"10.1002\/14651858.CD012167.pub2-BIB0100|cit100","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3389\/fimmu.2015.00353","article-title":"Regulation of T cell immunity in atopic dermatitis by microbes: the Yin and Yang of cutaneous inflammation","volume":"6","author":"Biedermann","year":"2015","journal-title":"Frontiers in Immunology"},{"issue":"4","key":"10.1002\/14651858.CD012167.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/j.1365-2133.2007.08412.x","article-title":"Diagnostic criteria for atopic dermatitis: a systematic review","volume":"158","author":"Brenninkmeijer","year":"2008","journal-title":"British Journal of Dermatology"},{"issue":"7","key":"10.1002\/14651858.CD012167.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.1398-9995.2010.01995.x","article-title":"Pathophysiology and therapy of pruritus in allergic and atopic diseases","volume":"65","author":"Buddenkotte","year":"2010","journal-title":"Allergy"},{"issue":"3","key":"10.1002\/14651858.CD012167.pub2-BIB0103|cit103","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/j.1525-1470.2005.22303.x","article-title":"The burden of atopic dermatitis: impact on the patient, family, and society","volume":"22","author":"Carroll","year":"2005","journal-title":"Pediatric Dermatology"},{"issue":"12","key":"10.1002\/14651858.CD012167.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1001\/archderm.140.12.1513","article-title":"The patient-oriented eczema measure: development and initial validation of a new tool for measuring atopic eczema severity from the patients' perspective","volume":"140","author":"Charman","year":"2004","journal-title":"Archives of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD012167.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"219","DOI":"10.4103\/0019-5154.110832","article-title":"Pharmacology of antihistamines","volume":"58","author":"Church","year":"2013","journal-title":"Indian Journal of Dermatology"},{"key":"10.1002\/14651858.CD012167.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000331890","article-title":"Itch and eczema","volume":"96","author":"Darsow","year":"2012","journal-title":"Chemical Immunology & Allergy"},{"issue":"7109","key":"10.1002\/14651858.CD012167.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD012167.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000247298","article-title":"Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis","volume":"186","author":"No authors","year":"1993","journal-title":"Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD012167.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","article-title":"Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use","volume":"19","author":"Finlay","year":"1994","journal-title":"Clinical and Experimental Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD012167.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/all.12270","article-title":"New insights into the epidemiology of childhood atopic dermatitis","volume":"69","author":"Flohr","year":"2014","journal-title":"Allergy"},{"issue":"4","key":"10.1002\/14651858.CD012167.pub2-BIB0111|cit111","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1111\/all.12112","article-title":"Characterization of different courses of atopic dermatitis in adolescent and adult patients","volume":"68","author":"Garmhausen","year":"2013","journal-title":"Allergy"},{"issue":"1","key":"10.1002\/14651858.CD012167.pub2-BIB0112|cit112","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/all.12959","article-title":"Evaluation of the measurement properties of symptom measurement instruments for atopic eczema: a systematic review","volume":"72","author":"Gerbens","year":"2017","journal-title":"Allergy"},{"issue":"5","key":"10.1002\/14651858.CD012167.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1159\/000086667","article-title":"Antihistamines in dermatology","volume":"18","author":"Greaves","year":"2005","journal-title":"Skin Pharmacology & Physiology"},{"issue":"7","key":"10.1002\/14651858.CD012167.pub2-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1517\/13543784.7.7.1045","article-title":"Therapeutic advantages of third generation antihistamines","volume":"7","author":"Handley","year":"1998","journal-title":"Expert Opinion on Investigational Drugs"},{"key":"10.1002\/14651858.CD012167.pub2-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2340\/00015555924447","article-title":"Diagnostic features of atopic dermatitis","volume":"92 Suppl","author":"Hanifin","year":"1980","journal-title":"Acta Dermato-Venereologica"},{"issue":"1","key":"10.1002\/14651858.CD012167.pub2-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1034\/j.1600-0625.2001.100102.x","article-title":"The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group","volume":"10","author":"Hanifin","year":"2001","journal-title":"Experimental Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD012167.pub2-BIB0117|cit117","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jaad.2017.12.077","article-title":"An assessment of the use of antihistamines in the management of atopic dermatitis","volume":"79","author":"He","year":"2018","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD012167.pub2-BIB0118|cit118","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1111\/all.12806","article-title":"Measurement properties of adult quality-of-life measurement instruments for eczema: a systematic review","volume":"71","author":"Heinl","year":"2016","journal-title":"Allergy"},{"issue":"4","key":"10.1002\/14651858.CD012167.pub2-BIB0119|cit119","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1111\/bjd.14966","article-title":"Measurement properties of quality-of-life measurement instruments for infants, children and adolescents with eczema: a systematic review","volume":"176","author":"Heinl","year":"2017","journal-title":"British Journal of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD012167.pub2-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1177\/120347540300700608","article-title":"Antihistamines in the treatment of dermatitis","volume":"7","author":"Herman","year":"2003","journal-title":"Journal of Cutaneous Medicine & Surgery"},{"key":"10.1002\/14651858.CD012167.pub2-BIB0121|cit121","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"37","key":"10.1002\/14651858.CD012167.pub2-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta4370","article-title":"Systematic review of treatments of atopic eczema","volume":"4","author":"Hoare","year":"2000","journal-title":"Health Technology Assessment"},{"issue":"9","key":"10.1002\/14651858.CD012167.pub2-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1046\/j.1365-2222.2003.01769.x","article-title":"Consensus Group on New-Generation Antihistamines (CONGA): present status and recommendations","volume":"33","author":"Holgate","year":"2003","journal-title":"Clinical and Experimental Allergy"},{"issue":"5","key":"10.1002\/14651858.CD012167.pub2-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1002\/cncr.27854","article-title":"Attrition rates, reasons, and predictive factors in supportive care and palliative oncology clinical trials","volume":"119","author":"Hui","year":"2013","journal-title":"Cancer"},{"issue":"5","key":"10.1002\/14651858.CD012167.pub2-BIB0125|cit125","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.jaci.2004.01.778","article-title":"The natural course of atopic dermatitis from birth to age 7 years and the association with asthma","volume":"113","author":"Illi","year":"2004","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"10.1002\/14651858.CD012167.pub2-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.2147\/PPA.S118121","article-title":"Factors affecting medication adherence in elderly people","volume":"10","author":"Jin","year":"2016","journal-title":"Patient Preference and Adherence"},{"issue":"5","key":"10.1002\/14651858.CD012167.pub2-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jaci.2003.12.591","article-title":"Revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of the World Allergy Organization, October 2003","volume":"113","author":"Johansson","year":"2004","journal-title":"Journal of Allergy & Clinical Immunology"},{"issue":"6 Pt 2","key":"10.1002\/14651858.CD012167.pub2-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"S622","DOI":"10.1067\/mai.2000.106153","article-title":"The effects of antihistamines on cognition and performance","volume":"105","author":"Kay","year":"2000","journal-title":"Journal of Allergy & Clinical Immunology"},{"issue":"3","key":"10.1002\/14651858.CD012167.pub2-BIB0129|cit129","doi-asserted-by":"publisher","first-page":"345","DOI":"10.2340\/00015555-1972","article-title":"Comparative cut-off value setting of pruritus intensity in visual analogue scale and verbal rating scale","volume":"95","author":"Kido-Nakahara","year":"2015","journal-title":"Acta Dermato-Venereologica"},{"issue":"12","key":"10.1002\/14651858.CD012167.pub2-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1001\/archderm.135.12.1522","article-title":"An evidence-based review of the efficacy of antihistamines in relieving pruritus in atopic dermatitis","volume":"135","author":"Klein","year":"1999","journal-title":"Archives of Dermatology"},{"key":"10.1002\/14651858.CD012167.pub2-BIB0131|cit131","volume-title":"Measurement in Medicine: A Practical Guide","author":"Knol","year":"2011"},{"issue":"2","key":"10.1002\/14651858.CD012167.pub2-BIB0132|cit132","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jaci.2012.12.1563","article-title":"The cutaneous innate immune response in patients with atopic dermatitis","volume":"131","author":"Kuo","year":"2013","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"9","key":"10.1002\/14651858.CD012167.pub2-BIB0133|cit133","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1001\/archderm.142.9.1190","article-title":"What is meant by a \"flare\" in atopic dermatitis? A systematic review and proposal","volume":"142","author":"Langan","year":"2006","journal-title":"Archives of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD012167.pub2-BIB0134|cit134","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1111\/bjd.12747","article-title":"How are eczema 'flares' defined? A systematic review and recommendation for future studies","volume":"170","author":"Langan","year":"2014","journal-title":"British Journal of Dermatology"},{"key":"10.1002\/14651858.CD012167.pub2-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1046\/j.0954-7894.2002.01314.x","article-title":"H1-antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects","volume":"32","author":"Leurs","year":"2002","journal-title":"Clinical & Experimental Allergy"},{"issue":"5","key":"10.1002\/14651858.CD012167.pub2-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"339-46","DOI":"10.1111\/j.1398-9995.1983.tb04128.x","article-title":"Development of asthma, allergic rhinitis and atopic dermatitis by the age of five years. A prospective study of 543 newborns","volume":"38","author":"Luoma","year":"1983","journal-title":"Allergy"},{"issue":"2","key":"10.1002\/14651858.CD012167.pub2-BIB0137|cit137","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.aller.2012.03.001","article-title":"The international study of asthma and allergies in childhood (ISAAC) phase three: a global synthesis","volume":"41","author":"Mallol","year":"2013","journal-title":"Allergologia et Immunopathologia"},{"issue":"5","key":"10.1002\/14651858.CD012167.pub2-BIB0138|cit138","first-page":"331","article-title":"Nonsedating histamine H1-receptor antagonists","volume":"8","author":"Mann","year":"1989","journal-title":"Clinical Pharmacy"},{"issue":"5-6","key":"10.1002\/14651858.CD012167.pub2-BIB0139|cit139","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/BF03256784","article-title":"Strategies to measure and improve patient adherence in clinical trials","volume":"23","author":"Matsui","year":"2012","journal-title":"Pharmaceutical Medicine"},{"issue":"18","key":"10.1002\/14651858.CD012167.pub2-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1001\/jama.279.18.1489","article-title":"CONSORT: an evolving tool to help improve the quality of reports of randomized controlled trials. Consolidated Standards of Reporting Trials","volume":"279","author":"Moher","year":"1998","journal-title":"JAMA"},{"issue":"7","key":"10.1002\/14651858.CD012167.pub2-BIB0141|cit141","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1111\/all.12619","article-title":"Atopic dermatitis from adolescence to adulthood in the TOACS cohort: prevalence, persistence and comorbidities","volume":"70","author":"Mortz","year":"2015","journal-title":"Allergy"},{"issue":"2","key":"10.1002\/14651858.CD012167.pub2-BIB0142|cit142","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1159\/000312629","article-title":"Olopatadine hydrochloride improves dermatitis score and inhibits scratch behavior in NC\/Nga mice","volume":"153","author":"Murota","year":"2010","journal-title":"International Archives of Allergy and Immunology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012167.pub2-BIB0143|cit143","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000370220","article-title":"Atopic dermatitis: global epidemiology and risk factors","volume":"66","author":"Nutten","year":"2015","journal-title":"Annals of Nutrition & Metabolism"},{"issue":"6","key":"10.1002\/14651858.CD012167.pub2-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.jaci.2009.10.009","article-title":"Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three","volume":"124","author":"Odhiambo","year":"2009","journal-title":"Journal of Allergy & Clinical Immunology"},{"issue":"1","key":"10.1002\/14651858.CD012167.pub2-BIB0145|cit145","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.alit.2016.08.009","article-title":"Assessment of severity and burden of pruritus","volume":"66","author":"Pereira","year":"2017","journal-title":"Allergology International"},{"issue":"4","key":"10.1002\/14651858.CD012167.pub2-BIB0146|cit146","doi-asserted-by":"publisher","first-page":"e17520","DOI":"10.1371\/journal.pone.0017520","article-title":"Health outcome measures in atopic dermatitis: a systematic review of trends in disease severity and quality-of-life instruments 1985-2010","volume":"6","author":"Rehal","year":"2011","journal-title":"PloS One"},{"key":"10.1002\/14651858.CD012167.pub2-BIB0147|cit147","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"8","key":"10.1002\/14651858.CD012167.pub2-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/j.1468-3083.2012.04635.x","article-title":"Guidelines for treatment of atopic eczema (atopic dermatitis) part I","volume":"26","author":"Ring","year":"2012","journal-title":"Journal of the European Academy for Dermatology & Venereology"},{"issue":"9","key":"10.1002\/14651858.CD012167.pub2-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/j.1468-3083.2012.04636.x","article-title":"Guidelines for treatment of atopic eczema (atopic dermatitis) part II","volume":"26","author":"Ring","year":"2012","journal-title":"Journal of the European Academy for Dermatology & Venereology"},{"issue":"6","key":"10.1002\/14651858.CD012167.pub2-BIB0150|cit150","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1111\/j.1365-2133.2012.10904.x","article-title":"Eczema among adults: prevalence, risk factors and relation to airway diseases. Results from a large-scale population survey in Sweden","volume":"166","author":"R\u00f6nmark","year":"2012","journal-title":"British Journal of Dermatology"},{"issue":"9","key":"10.1002\/14651858.CD012167.pub2-BIB0151|cit151","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1111\/j.1398-9995.2012.02874.x","article-title":"Towards global consensus on outcome measures for atopic eczema research: results of the HOME II meeting","volume":"67","author":"Schmitt","year":"2012","journal-title":"Allergy"},{"issue":"6","key":"10.1002\/14651858.CD012167.pub2-BIB0152|cit152","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1016\/j.jaci.2013.07.008","article-title":"Assessment of clinical signs of atopic dermatitis: a systematic review and recommendation","volume":"132","author":"Schmitt","year":"2013","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"4","key":"10.1002\/14651858.CD012167.pub2-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.jaci.2014.07.043","article-title":"The Harmonising Outcome Measures for Eczema (HOME) statement to assess clinical signs of atopic eczema in trials","volume":"134","author":"Schmitt","year":"2014","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"2","key":"10.1002\/14651858.CD012167.pub2-BIB0154|cit154","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jaad.2014.03.030","article-title":"Guidelines of care for the management of atopic dermatitis. Section 3. Management and treatment with phototherapy and systemic agents","volume":"71","author":"Sidbury","year":"2014","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD012167.pub2-BIB0155|cit155","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.jaci.2013.08.031","article-title":"Adult eczema prevalence and associations with asthma and other health and demographic factors: a US population-based study","volume":"132","author":"Silverberg","year":"2013","journal-title":"Journal of Allergy & Clinical Immunology"},{"issue":"7","key":"10.1002\/14651858.CD012167.pub2-BIB0156|cit156","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1038\/jid.2013.19","article-title":"Climatic factors are associated with childhood eczema prevalence in the United States","volume":"133","author":"Silverberg","year":"2013","journal-title":"Journal of Investigative Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD012167.pub2-BIB0157|cit157","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0091-6749(99)70389-1","article-title":"Prospective, long-term safety evaluation of the H1-receptor antagonist cetirizine in very young children with atopic dermatitis. ETAC Study Group. Early Treatment of the Atopic Child","volume":"104","author":"Simons","year":"1999","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"21","key":"10.1002\/14651858.CD012167.pub2-BIB0158|cit158","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1056\/NEJMra033121","article-title":"Advances in H1-antihistamines","volume":"351","author":"Simons","year":"2004","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD012167.pub2-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/9781444300918.ch25","article-title":"Antihistamines","volume-title":"Allergy and Allergic Diseases","author":"Simons","year":"2008"},{"issue":"6","key":"10.1002\/14651858.CD012167.pub2-BIB0160|cit160","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/j.jaci.2011.09.005","article-title":"Histamine and H1-antihistamines: celebrating a century of progress","volume":"128","author":"Simons","year":"2011","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"5","key":"10.1002\/14651858.CD012167.pub2-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1097\/00008480-200210000-00012","article-title":"Atopic diseases of childhood","volume":"14","author":"Stone","year":"2002","journal-title":"Current Opinion in Pediatrics"},{"issue":"1","key":"10.1002\/14651858.CD012167.pub2-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1034\/j.1600-0625.2002.110102.x","article-title":"Pathophysiology of pruritus in atopic dermatitis: an overview","volume":"11","author":"St\u00e4nder","year":"2002","journal-title":"Experimental Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD012167.pub2-BIB0163|cit163","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1111\/j.1365-2230.2004.01618.x","article-title":"Effects of bepotastine, cetirizine, fexofenadine and olopatidine on histamine induced wheal and flare-response, sedation and psychomotor performance","volume":"29","author":"Takahashi","year":"2004","journal-title":"Experimental Dermatology"},{"key":"10.1002\/14651858.CD012167.pub2-BIB0164|cit164","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/9781444300161.ch19","article-title":"Atopic eczema","volume-title":"Evidence-based Dermatology","author":"Thomas","year":"2008"},{"issue":"4","key":"10.1002\/14651858.CD012167.pub2-BIB0165|cit165","doi-asserted-by":"crossref","first-page":"e0124770","DOI":"10.1371\/journal.pone.0124770","article-title":"Validation of treatment escalation as a definition of atopic eczema flares","volume":"10","author":"Thomas","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1002\/14651858.CD012167.pub2-BIB0166|cit166","doi-asserted-by":"crossref","first-page":"24642","DOI":"10.3402\/ecrj.v2.24642","article-title":"Epidemiology and natural history of atopic diseases","volume":"2","author":"Thomsen","year":"2015","journal-title":"European Clinical Respiratory Journal"},{"key":"10.1002\/14651858.CD012167.pub2-BIB0167|cit167","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/978-3-319-33142-3_19","article-title":"Atopic dermatitis","volume-title":"Pruritus","author":"Tominaga","year":"2016"},{"issue":"6","key":"10.1002\/14651858.CD012167.pub2-BIB0168|cit168","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1471-2288-6-52","article-title":"A system for rating the stability and strength of medical evidence","volume":"19","author":"Treadwell","year":"2006","journal-title":"BMC Medical Research Methodology"},{"issue":"1","key":"10.1002\/14651858.CD012167.pub2-BIB0169|cit169","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010334","article-title":"Interventions for hirsutism excluding laser and photoepilation therapy","author":"Zuuren","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD012167.pub2-BIB0170|cit170","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012119.pub2","article-title":"Emollients and moisturisers for eczema","author":"Zuuren","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD012167.pub2-BIB0171|cit171","doi-asserted-by":"crossref","first-page":"480","DOI":"10.2340\/00015555-1761","article-title":"Is adult atopic eczema more common than we think? A population-based study in Danish adults","volume":"94","author":"Vinding","year":"2014","journal-title":"Acta Dermato-Venereologica"},{"issue":"12","key":"10.1002\/14651858.CD012167.pub2-BIB0172|cit172","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1016\/j.jada.2011.09.036","article-title":"How much of racial\/ethnic disparities in dietary intakes, exercise, and weight status can be explained by nutrition- and health-related psychosocial factors and socioeconomic status among US adults?","volume":"111","author":"Wang","year":"2011","journal-title":"Journal of the American Dietetic Association"},{"issue":"10023","key":"10.1002\/14651858.CD012167.pub2-BIB0173|cit173","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/S0140-6736(15)00149-X","article-title":"Atopic dermatitis","volume":"387","author":"Weidinger","year":"2016","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD012167.pub2-BIB0174|cit174","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/ddg.12871","article-title":"S2k guideline on diagnosis and treatment of atopic dermatitis - short version","volume":"14","author":"Werfel","year":"2016","journal-title":"Journal der Deutschen Dermatologischen Gesellschaft [Journal of the German Society of Dermatology]"},{"issue":"3","key":"10.1002\/14651858.CD012167.pub2-BIB0175|cit175","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1365-2133.1994.tb08530.x","article-title":"The UK Working Party's diagnostic criteria for atopic dermatitis","volume":"131","author":"Williams","year":"1994","journal-title":"British Journal of Dermatology"},{"key":"10.1002\/14651858.CD012167.pub2-BIB0176|cit176","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1146\/annurev.pa.36.040196.001313","article-title":"Cardiac actions of antihistamines","volume":"36","author":"Woosley","year":"1996","journal-title":"Annual Review of Pharmacology & Toxicology"},{"issue":"4","key":"10.1002\/14651858.CD012167.pub2-BIB0177|cit177","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1185\/03007995.2012.672405","article-title":"Safety considerations in the management of allergic diseases: focus on\u00a0antihistamines","volume":"28","author":"Yanai","year":"2012","journal-title":"Current Medical Research & Opinion"},{"issue":"4","key":"10.1002\/14651858.CD012167.pub2-BIB0178|cit178","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1007\/s11882-008-0049-z","article-title":"What causes itch in atopic dermatitis?","volume":"8","author":"Yosipovitch","year":"2008","journal-title":"Current Allergy and Asthma Reports"},{"issue":"4","key":"10.1002\/14651858.CD012167.pub2-BIB0179|cit179","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012167","article-title":"Oral H1 antihistamines as \u2018add-on\u2019 therapy to topical treatment for eczema","author":"Apfelbacher","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD012167.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T23:00:44Z","timestamp":1694559644000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD012167.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Skin Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,1,22]]},"references-count":179,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd012167.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,22]]}}}